This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_LIVER_GALLBLADDER_BILE_EXALLC for full statistics.
Carcinoma in situ of liver, gallbladder and bile ducts
CD2_INSITU_LIVER_GALLBLADDER_BILE
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions
not C3_LIVER_INTRAHEPATIC_BILE_DUCTS
or not C3_GALLBLADDER
or not C3_BILIARY_TRACT
427957
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
D01.5&
Hospital discharge: ICD-9
2308
Cause of death: ICD-10
D01.5&
Cause of death: ICD-9
2308
Cancer registry: Topography ICD-O-3
C2[2-4]
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
2
3 out of 7 registries used, show all original rules.
16
Check minimum number of events None
16
Include endpoints None
16
Remove individuals based on genotype QC
15
CD2_INSITU_LIVER_GALLBLADDER_BILE
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D01
Name in latin
Carcinoma in situ tracheae
Not enough data for upset plot.
Not enough data for upset table.
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of liver, gallbladder and bile ducts
based on the number of shared cases.
Broader endpoints:
- Carcinoma in situ of liver, gallbladder and bile ducts (controls excluding all cancers)
- Carcinoma in situ of other and unspecified digestive organs (controls excluding all cancers)
- Carcinoma in situ of other and unspecified digestive organs
- In situ neoplasms
- In situ neoplasms (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 15 | 9 | 6 |
| Unadjusted prevalence (%) | 0.00 | 0.00 | 0.00 |
| Mean age at first event (years) | 60.30 | 54.80 | 68.56 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_INSITU_LIVER_GALLBLADDER_BILE – Carcinoma in situ of liver, gallbladder and bile ducts
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Carcinoma in situ of liver, gallbladder and bile ducts
↥Endpoint not on priority list, no data to show.